Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Advertising

Press Release

Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market: Industry Analysis & Outlook (2018-2025) - Multiple Growth Factors are Driving the Market - ResearchAndMarkets.com

Research and Markets
Posted on: 23 Feb 18

The "Global PARP (Poly ADP-Ribose Polymerase) Inhibitor Market: Industry Analysis & Outlook (2018-2025)" report has been added to ResearchAndMarkets.com's offering.

The report provides an extensive research and detailed analysis of the present market along with future outlook. The report discusses the major growth drivers and challenges of the market, covering the U.S. and Europe region along with the global market. The four major players: Tesaro Inc., Clovis Oncology, AstraZeneca and Abbvie Inc. are being profiled along with their key financials and strategies for growth.

The U.S. is the major market of PARP inhibitor supported by PARPi for ovarian cancer in the market. The U.S. region is likely to experience further growth of PARP inhibitor market with upcoming PARP inhibitors and growing cases of cancer.

Market Dynamics

Growth Drivers

  • Rising Cancer Cases
  • Rising Healthcare Expenditure
  • Increased Ageing Population
  • Increasing GDP Per Capita
  • Vast Unmet Medical Need

Key Trends & Developments

  • Combinations of PARP Inhibitors and Immunotherapy
  • Development of Ovarian Cancer Diagnosis Methods and Biomarkers
  • Strong Research & Development Efforts by Companies
  • Increasing Awareness of Early Diagnosis and Treatment of Disease

Challenges

  • Side Effects of PARP Inhibitors
  • Resistance to PARP Inhibitors
  • Regulatory Challenges

Key Topics Covered:

1. Market Overview

1.1 DNA Damage Response (DDR)

1.2 DNA Repair Pathways

1.3 PARP Inhibitor

1.4 Inhibiting PARP Mechanism

1.5 PARP for Cancer Treatment

1.6 PARP Inhibitor Drugs

2. Global Market Analysis

2.1 Global PARP Inhibitor Market

2.2 Global PARP Inhibitor Market by Drug Type

3. Regional Market

3.1 The U.S.

3.2 European Union

4. Market Dynamics

4.1 Growth Drivers

4.2 Key Trends & Developments

4.3 Challenges

5. Competitive Landscape

5.1 Global Market

6. Company Profiles

  • Tesaro Inc.
  • Clovis Oncology
  • AstraZeneca
  • Abbvie Inc.

For more information about this report visit https://www.researchandmarkets.com/research/3ngfs9/global_parp_poly?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180223005693/en/

Business Wire
www.businesswire.com

Last updated on: 23/02/2018

Advertising
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.